Carson Wealth (CWM LLC)
ZBIO

Carson Wealth (CWM LLC)’s Zenas BioPharma ZBIO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.8K Sell
1,472
-706
-32% -$15.8K ﹤0.01% 4190
2025
Q4 		$79K Buy
2,178
+709
+48% +$23.3K ﹤0.01% 3253
2025
Q3 		$33K Buy
1,469
+4
+0.3% +$65 ﹤0.01% 3830
2025
Q2 		$14K Buy
1,465
+989
+208% +$9.63K ﹤0.01% 4135
2025
Q1 		$4K Buy
+476
New +$3.73K ﹤0.01% 4587

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ZBIO Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Zenas BioPharma (ZBIO) stake by 32% in Q1 2026, selling an estimated $15.8K and leaving 1,472 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

Carson Wealth (CWM LLC) first reported a position in ZBIO in Q1 2025 and has held it in 5 quarters since. The position peaked at $79K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1,472 shares of Zenas BioPharma worth $28.8K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 706 Zenas BioPharma shares in Q1 2026, an estimated $15.8K.
  • Zenas BioPharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4190 holding.
  • Carson Wealth (CWM LLC) first reported a position in Zenas BioPharma in Q1 2025 and has held it in 5 quarters since.
  • Carson Wealth (CWM LLC)'s Zenas BioPharma position peaked at $79K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.